Celgene (CELG) Tops Q2 EPS by 5c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Celgene (CELG) PT Raised to $101 at SunTrust Robinson Humphrey
July 27, 2018 8:06 AM EDTSunTrust Robinson Humphrey raised its price target on Celgene (NASDAQ: CELG) to $101.00 (from $96.00) while maintaining a Hold rating.
Analyst Yatin Suneja commented, "CELG reported 2Q sales above consensus on good performances from all core products except Otezla and Abraxane, while... More
Celgene (CELG) PT Raised to $93 at Morgan Stanley
July 27, 2018 7:37 AM EDTMorgan Stanley raised its price target on Celgene (NASDAQ: CELG) to $93.00 (from $91.00) while maintaining a Equalweight rating.
... More